• Western blot analysis of lysates from Hela cells, primary antibody was diluted at 1:1000, 4°C over night

Anti-MED12L antibody (1848-1898 aa) (STJ194804)

SKU:
STJ194804

Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Mediator of RNA polymerase II transcription subunit 12-like protein (1848-1898 aa) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: MED12L
Gene ID: 116931
Uniprot ID: MD12L_HUMAN
Immunogen Region: 1848-1898 aa
Specificity: This antibody detects endogenous levels of MD12L at Human/Mouse
Immunogen: Synthesized peptide derived from the human MD12L at the amino acid range 1848-1898
Protein Name Mediator Of Rna Polymerase Ii Transcription Subunit 12-Like Protein
Mediator Complex Subunit 12-Like Protein
Thyroid Hormone Receptor-Associated-Like Protein
Trinucleotide Repeat-Containing Gene 11 Protein-Like
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Mediator Of Rna Polymerase Ii Transcription Subunit 12-Like Protein antibody
Anti-Mediator Complex Subunit 12-Like Protein antibody
Anti-Thyroid Hormone Receptor-Associated-Like Protein antibody
Anti-Trinucleotide Repeat-Containing Gene 11 Protein-Like antibody
Anti-MED12L antibody
Anti-KIAA1635 antibody
Anti-TNRC11L antibody
Anti-TRALP antibody
Anti-TRALPUSH antibody
Anti-PRO0314 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance